Literature DB >> 23053772

Microbial keratitis following vegetative matter injury.

Mukesh Taneja1, Jatin N Ashar, Anurag Mathur, Suma Nalamada, Prashant Garg.   

Abstract

The purpose of the present study was to analyze the microbiological profile of cases of keratitis following trauma with vegetative matter in a tertiary care center. A retrospective review of the medical records of 49 patients with keratitis following vegetative matter injury over a 3-month period was performed. All patients underwent corneal scraping for smears and inoculation onto various culture media. The microbiological profile was based on the smear and culture reports. For patients who were culture-negative, outcome after standard empirical antibacterial therapy as per hospital protocol was analyzed. Thirteen patients with corneal ulcers had fungal etiology, eight had bacterial etiology, and two had protozoal etiology, while 13 patients were polymicrobial and 13 were culture-negative. Polymicrobial infections were mainly bacterial (eight cases), and the remaining five cases had coexistent fungal and bacterial etiology. The treatment was directed to the specific organism and patients improved with medical or surgical therapy. Only a third of culture-negative cases showed fungal etiology on biopsy or histopathology after keratoplasty while a third showed improvement with therapy. Corneal infections following vegetative matter trauma show a varied etiological profile; however, bacterial and polymicrobial infections are more prevalent. Empirical anti-fungal therapy, as commonly practiced, must be avoided in cases with vegetative matter injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053772     DOI: 10.1007/s10792-012-9643-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  9 in total

1.  Concurrent use of 5% natamycin and 2% econazole for the management of fungal keratitis.

Authors:  N Venkatesh Prajna; Praveen K Nirmalan; Rajendran Mahalakshmi; Prajna Lalitha; Muthiah Srinivasan
Journal:  Cornea       Date:  2004-11       Impact factor: 2.651

Review 2.  Current diagnosis and treatment of corneal ulcers.

Authors:  W H Benson; J D Lanier
Journal:  Curr Opin Ophthalmol       Date:  1998-08       Impact factor: 3.761

3.  A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis.

Authors:  N V Prajna; R K John; P K Nirmalan; P Lalitha; M Srinivasan
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

4.  Empirical or culture-guided therapy for microbial keratitis? A plea for data.

Authors:  P J McDonnell
Journal:  Arch Ophthalmol       Date:  1996-01

5.  Microbial keratitis in South India: influence of risk factors, climate, and geographical variation.

Authors:  M Jayahar Bharathi; R Ramakrishnan; R Meenakshi; S Padmavathy; C Shivakumar; M Srinivasan
Journal:  Ophthalmic Epidemiol       Date:  2007 Mar-Apr       Impact factor: 1.648

6.  Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study.

Authors:  M Jayahar Bharathi; R Ramakrishnan; Samala Vasu; R Meenakshi; R Palaniappan
Journal:  Indian J Ophthalmol       Date:  2003-12       Impact factor: 1.848

7.  Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade.

Authors:  Usha Gopinathan; Savitri Sharma; Prashant Garg; Gullapalli N Rao
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

8.  Investigative modalities in infectious keratitis.

Authors:  Noopur Gupta; Radhika Tandon
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

9.  Medical management approach to infectious keratitis.

Authors:  Nikhil S Gokhale
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

  9 in total
  1 in total

1.  Corneal Debridement Combined with Intrastromal Voriconazole for Recalcitrant Fungal Keratitis.

Authors:  Yajie Sun; Zhuo Sun; Yukai Chen; Guohua Deng
Journal:  J Ophthalmol       Date:  2018-02-19       Impact factor: 1.909

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.